UNIVERSITY OF ALABAMA AT BIRMINGHAM
Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS
Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS is a funding opportunity from UNIVERSITY OF ALABAMA AT BIRMINGHAM, up to 321747, closing April 30, 2027.
Apr 30, 2027
(273d left)Overview
PROJECT SUMMARY Although acute viral replication has been well controlled with combination antiretroviral therapies (cART) in the early stage of HIV infection long-term HIV-1 viral protein exposure within the CNS causes dysregulation of monoamine transmission, which has been implicated as a key factor in HIV…